Abstract
This Viewpoint discusses the settlement agreements reached against several major pharmaceutical distributors resulting from the US opioid epidemic and how those funds will be distributed amongst the states.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have